{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:41:12Z","timestamp":1792287672404,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,2,23]],"date-time":"2013-02-23T00:00:00Z","timestamp":1361577600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s00404-013-2762-7","type":"journal-article","created":{"date-parts":[[2013,2,22]],"date-time":"2013-02-22T00:42:30Z","timestamp":1361493750000},"page":"393-400","source":"Crossref","is-referenced-by-count":26,"title":["Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II"],"prefix":"10.1007","volume":"288","author":[{"given":"Cheguo","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana S.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura G.","family":"Franko-Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica C.","family":"Prasnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vienna Mackey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Fuselier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Coy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,23]]},"reference":[{"key":"2762_CR1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1535-6108(03)00052-7","volume":"3","author":"I Maillard","year":"2003","unstructured":"Maillard I, Pear WS (2003) Notch and cancer: best to avoid the ups and downs. Cancer Cell 3:203\u2013205","journal-title":"Cancer Cell"},{"key":"2762_CR2","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1038\/onc.2008.225","volume":"27","author":"GP Dotto","year":"2008","unstructured":"Dotto GP (2008) Notch tumor suppressor function. Oncogene 27:5115\u20135123","journal-title":"Oncogene"},{"key":"2762_CR3","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1007\/s00018-007-7164-1","volume":"64","author":"U Koch","year":"2007","unstructured":"Koch U, Radtke F (2007) Notch and cancer: a double-edged sword. Cell Mol Life Sci 64:2746\u20132762","journal-title":"Cell Mol Life Sci"},{"key":"2762_CR4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.yexcr.2005.01.015","volume":"305","author":"C Talora","year":"2005","unstructured":"Talora C, Cialfi S, Segatto O (2005) Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathways. Exp Cell Res 305:343\u2013354","journal-title":"Exp Cell Res"},{"key":"2762_CR5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1634\/theoncologist.2011-0269","volume":"17","author":"LG Franko-Tobin","year":"2011","unstructured":"Franko-Tobin LG, Mackey LV, Huang W (2011) Notch1-mediated tumor suppression in cervical cancer with the involvement of sst signaling and its application in enhanced SSTR-targeted therapeutics. Oncologist 17:220\u2013232","journal-title":"Oncologist"},{"key":"2762_CR6","first-page":"37","volume":"53","author":"M Kostrouchov\u00e1","year":"2007","unstructured":"Kostrouchov\u00e1 M, Kostrouch Z, Kostrouchov\u00e1 M (2007) Valproic acid, a molecular lead to multiple regulatory pathways. Folia Biol (Praha) 53:37\u201349","journal-title":"Folia Biol (Praha)"},{"key":"2762_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jss.2008.03.008","volume":"148","author":"CS Platta","year":"2008","unstructured":"Platta CS, Greenblatt DY, Kunnimalaiyaan M (2008) Valproic acid induces Notch1 signaling in small cell lung cancer cells. J Surg Res 148:31\u201337","journal-title":"J Surg Res"},{"key":"2762_CR8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","volume":"34","author":"A Duenas-Gonzalez","year":"2008","unstructured":"Duenas-Gonzalez A, Candelaria M, Perez-Plascencia C (2008) Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors. Cancer Treat Rev 34:206\u2013222","journal-title":"Cancer Treat Rev"},{"key":"2762_CR9","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/pros.20587","volume":"67","author":"S Shabbeer","year":"2007","unstructured":"Shabbeer S, Kortenhorst MS, Kachhap S, Galloway N, Rodriguez R, Carducci MA (2007) Multiple molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo. Prostate 67:1099\u20131110","journal-title":"Prostate"},{"key":"2762_CR10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jss.2008.08.004","volume":"159","author":"JT Adler","year":"2010","unstructured":"Adler JT, Hottinger DG, Kunnimalaiyaan M (2010) Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride. J Surg Res 159:640\u2013644","journal-title":"J Surg Res"},{"key":"2762_CR11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jb\/mvn074","volume":"144","author":"S Sami","year":"2008","unstructured":"Sami S, H\u00f6ti N, Xu HM, Shen Z, Huang X (2008) Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo. J Biochem 144:357\u2013362","journal-title":"J Biochem"},{"key":"2762_CR12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/156720111793663633","volume":"8","author":"L Sun","year":"2011","unstructured":"Sun L, Coy DH (2011) Somatostatin receptor-targeted anti-cancer therapy. Cur Drug Deliv 8:2\u201310","journal-title":"Cur Drug Deliv"},{"key":"2762_CR13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/CAD.0b013e32801261b6","volume":"18","author":"L Sun","year":"2007","unstructured":"Sun L, Luo J, Mackey VL (2007) Effects of camptothecin on tumor cell proliferation and angiogenesis when coupled to a bombesin analog used as a targeted delivery vector. Anticancer Drugs 18:341\u2013348","journal-title":"Anticancer Drugs"},{"key":"2762_CR14","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.1158\/0008-5472.CAN-07-2253","volume":"67","author":"AM Eastham","year":"2007","unstructured":"Eastham AM, Spencer H, Soncin F (2007) Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res 67:11254\u201311262","journal-title":"Cancer Res"},{"key":"2762_CR15","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/sj.bjc.6605543","volume":"102","author":"Y Kato","year":"2010","unstructured":"Kato Y, Yashiro M, Noda S (2010) Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12\/Hypo, derived from a scirrhous gastric carcinoma. Br J Cancer 102:898\u2013907","journal-title":"Br J Cancer"},{"key":"2762_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2613.2006.00479.x","volume":"87","author":"M Forino","year":"2006","unstructured":"Forino M, Torregrossa R, Ceol M (2006) TGFb1 induces epithelial\u2013mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture. Int J Exp Pathol 87:197\u2013208","journal-title":"Int J Exp Pathol"},{"key":"2762_CR17","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/dneu.20744","volume":"69","author":"L Lossi","year":"2009","unstructured":"Lossi L, Gambino G, Ferrini F (2009) Posttranslational regulation of BCL2 levels in cerebellar granule cells: a mechanism of neuronal survival. Dev Neurobiol 69:855\u2013870","journal-title":"Dev Neurobiol"},{"key":"2762_CR18","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.1158\/0008-5472.CAN-07-0932","volume":"67","author":"K Higashikawa","year":"2007","unstructured":"Higashikawa K, Yoneda S, Tobiume K (2007) Snail-induced down-regulation of DeltaNp63alpha acquires invasive phenotype of human squamous cell carcinoma. Cancer Res 67:9207\u20139213","journal-title":"Cancer Res"},{"key":"2762_CR19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ygyno.2004.06.023","volume":"94","author":"V Gagnon","year":"2004","unstructured":"Gagnon V, Mathieu I, Sexton \u00c9 (2004) AKT involvement in cisplatin chemoresistance of human uterine cancer cells. Gynecol Oncol 94:785\u2013795","journal-title":"Gynecol Oncol"},{"key":"2762_CR20","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1177\/1947601911407325","volume":"1","author":"MM Georgeseu","year":"2010","unstructured":"Georgeseu MM (2010) PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control. Genes Cancer 1:1170\u20131177","journal-title":"Genes Cancer"},{"key":"2762_CR21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP (2002) Epithelial-mesenchymal transitions in tumor progression. Nat Rev Cancer 2:442\u2013454","journal-title":"Nat Rev Cancer"},{"key":"2762_CR22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2002-0007","volume":"24","author":"JC Reubi","year":"2003","unstructured":"Reubi JC (2003) Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 24:389\u2013427","journal-title":"Endocr Rev"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-013-2762-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-013-2762-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-013-2762-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:56:44Z","timestamp":1559051804000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-013-2762-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,23]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["2762"],"URL":"https:\/\/doi.org\/10.1007\/s00404-013-2762-7","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,23]]}}}